|
Volumn 47, Issue 4 A SPEC. ISSUE, 1997, Pages 555-559
|
Ebrotidine versus ranitidine in the treatment of acute duodenal ulcer: A multicentre, randomized, double-blind, controlled clinical trial
a b c d a e e e e e |
Author keywords
CAS 100981 43 9; Duodenal ulcer, risk factors; Ebrotidine FI 3542. gastroprotection, multicentre study; H2 Receptor antagonist; Ranitidine
|
Indexed keywords
EBROTIDINE;
HISTAMINE H2 RECEPTOR ANTAGONIST;
RANITIDINE;
ADULT;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DUODENUM ULCER;
FEMALE;
GASTROINTESTINAL ENDOSCOPY;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
ORAL DRUG ADMINISTRATION;
RANDOMIZED CONTROLLED TRIAL;
RISK FACTOR;
SMOKING;
SYMPTOMATOLOGY;
ULCER HEALING;
ABDOMINAL PAIN;
ADULT;
BENZENESULFONATES;
DOUBLE-BLIND METHOD;
DUODENAL ULCER;
FEMALE;
HISTAMINE H2 ANTAGONISTS;
HUMANS;
MALE;
MIDDLE AGED;
RANITIDINE;
SMOKING;
THIAZOLES;
|
EID: 8244247775
PISSN: 00044172
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (4)
|
References (18)
|